Artificial liver support - "bridge to transplantation?"

References

• Trey C, Lipworth L, Chalmers TC, et al. Fulminant hepatic failure. Presumable contribution to halothane. N. Engl. J. Med. 1968; 279: 798–801.
   PubMed Web of Science ®Google Scholar
• Davidson CS, McDermott WV, Jr., Trey C. Sustaining life during fulminant hepatic failure. Ann. Intern. Med. 1969; 71: 415–418.
   Google Scholar
• Kerr DN, Elliott RW, Swinney J. Regular haemodialysis in the treatment of chronic renal failure. Proc. R. Soc. Med. 1966; 59: 667–670.
   Google Scholar
• Rees HA, Goldberg A, Cochrane AL, Williams MJ, Donald KW. Renal haemodialysis in porphyria. Lancet 1967; 1: 919–922.
   Google Scholar
• Zysno E, Reichenmiller HE, Dun F. EEG studies in uraemic patients during extracorporeal haemodialysis or intermittent peritoneal dialysis. Electroencephalogr. Clin. Neurophysiol. 1967; 23: 384–384.
   Google Scholar
• Zysno E, Reichenmiller HE, Durr F. [Longitudinal EEG study of uremic patients treated by extracorporeal hemodialysis and by intermittent peritoneal dialysis]. Rev. Neurol. Paris. 1967; 117: 128–130.
   Google Scholar
• Kiley JE, Pender JC, Welch CS, and Welch HF. Treatment of hepatic coma by hemodialysis. Trans. Am. Soc. Artif. Intern. Organs 1957; 3: 86–88.
   Google Scholar
• Opolon P. Lavallard MC, Crubille C, et al. [Encephalopathy in acute hepatic atrophy. Effect of the purification of middle molecules. Preliminary results]. Nouv. Presse Med. 1975; 4: 2987–2991.
   PubMedGoogle Scholar
• Opolon P, LavaBard MC, Crubille C, et al. [Effect of molecular filtration on encephalopathy during coma caused by acute hepatic atrophy: preliminary results]. Med. Chir. Dig. 1975; 4\(suppl 2): 37–41.
   Google Scholar
• Denis J, Opolon P, Nusinovici V, Granger A, Darnis F. Treatment of encephalopathy during fulminant hepatic failure by haemodialysis with high permeability membrane. Gut 1978; 19: 787–793.
   Google Scholar
• Stange J and Mitzner S. A carrier-mediated transport of toxns in a hybrid membrane. Safety barrier between a patients blood and a bioartificial liver. Int. J. Artif. Organs 1996; 19(11): 677–691.
   Google Scholar
• Gstraunthaler G, Pfaller W, Kotanko P. Glutathione depletion and in vitro lipid peroxidation in mercury or maleate induced acute renal failure. Biochem. Pharmacol. 1983; 32: 2969–2972.
   Google Scholar
• Pacanis A, Rogulski J. Studies on chemical and enzymatic synthesis of maleyl-CoA. J. Biol. Chem. 1981; 256: 13030–13034.
   PubMedGoogle Scholar
• Clemmesen JO, Larsen FS, Ejlersen E, Schiodt FV, Ott P. Hansen BA Haemodynamic changes after high-volume plasmapheresis in patients with chronic and acute liver failure. Fur. J. Gastroenterol. Hepatol. 1997; 9: 55–60.
   Google Scholar
• Davenport A, Will EJ, Davison AM. Continuous vs. intermittent forms of haemofiltration and/or dialysis in the management of acute renal failure in patients with defective cerebral autoregulation at risk of cerebral oedema. Cont rib. Nephrol. 1991; 93: 225–233.
   Google Scholar
• Davenport A, Will EJ, Davison AM, et al. Changes in intracranial pressure during machine and continuous haemofiltration. Int. J. Artif. Organs 1989; 12: 439–444.
   PubMed Web of Science ®Google Scholar
• Davenport A, Will EJ, Davison AM. The effect of lactate-buffered solutions on the acid-base status of patients with renal failure. Nephrol. Dial. Transplant. 1989; 4: 800–804.
   Google Scholar
• Davenport A, Will EJ, Davison AM. Comparison of the use of standard heparin and prostacyclin anticoagulation in spontaneous and pump-driven extracorporeal circuits in patients with combined acute renal and hepatic failure. Nephron 1994; 66: 431–437.
   Google Scholar
• Bellomo R, Ronco C. Circulation of the continuous artificial kidney: blood flow, pressures, clearances and the search for the best. Blood Puri': 1997; 15: 354–365.
   PubMed Web of Science ®Google Scholar
• Ronco C, Bellomo R. Basic mechanisms and definitions for continuous renal replacement therapies. Int. J. Art if Organs 1996; 19: 95–99.
   PubMed Web of Science ®Google Scholar
• Bellomo R, Ronco C. Continuous versus intermittent renal replacement therapy in the intensive care unit. Kidney Int. Suppl. 1998; 66: S125–8.
   PubMedGoogle Scholar
• Bellomo R, Baldwin I, Cole L, Ronco C. Preliminary experience with high-volume hemofiltration in human septic shock. Kidney Int. Suppl. 1998; 66: S182–5.
   PubMedGoogle Scholar
• Bernal W, Wong T, Wendon J. High-volume continuous venous-venous haemofiltration in hyper-acute liver failure: A pilot study. Critical Care 1999; 3: 106–1106.
   Google Scholar
• Gazzard BG, Weston MJ, Murray Lyon IM, et al. Charcoal haemoperfusion in the treatment of fulminant hepatic failure. Lancet 1974; 1: 1301–1307.
   PubMed Web of Science ®Google Scholar
• Weston MJ, Gazzard BG, Buxton BH, et al. Effects of haemoperfusion through charcoal or XAD-2 resin on an animal model of fulminant liver failure. Gut 1974; 15: 482–486.
   PubMed Web of Science ®Google Scholar
• Weston MJ, Langley PG, Rubin MH, Hanid MA, Mellon P, Williams R. Platelet function in fulminant hepatic failure and effect of charcoal haemoperfusion. Gut 1977; 18: 897–902.
   PubMed Web of Science ®Google Scholar
• Gelfrand MC, Winchester JF. Treatment of hepatic coma with hemoperfusion through polyacrylamide hydrogel-coated charcoal. Kidney Int. 1976; 12: 239–243.
   Google Scholar
• Gimson AE, Braude S. Mellon PJ, Canalese J, Williams R. Earlier charcoal haemoperfusion in fulminant hepatic failure. Lancet 1982; 2: 681–683.
   Google Scholar
• Gimson AE, Langley PG, Hughes RD, et al. Prostacyclin to prevent platelet activation during charcoal haemoperfusion in fulminant hepatic failure. Lancet 1980; 1: 173–175.
   PubMed Web of Science ®Google Scholar
• O'Grady JG, Gimson AE, O'Brien CJ, Pucknell A, Hughes RD, Williams R. Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure. Gastroenterology 1988; 94: 1186–1192.
   PubMed Web of Science ®Google Scholar
• Schechter DC, Nealon TF, Gibbon JH. A simple extracorporeal device for reducing elevated blood ammonia levels. Surgery 1958;44:892–897.
   Google Scholar
• Juggi JS. Extracorporeal cation exchange circuits in the treatment of hyperammonemia of hepatic failure. Med. J. Aust. 1973; 60: 926–930.
   Google Scholar
• Juggi JS. Haemoperfusion through cation exchange columns in the treatment of ammonia intoxication in dogs. Proc. Soc. Exp. Biol. Med. 1971; 137: 39–42.
   PubMed Web of Science ®Google Scholar
• Juggi JS. In-vivo studies with a cation exchange resin mixture in the removal of excessive ammonium from the extracorporeal circulation system. Aust. N. Z. J. Surg. 1971; 41: 194–201.
   PubMedGoogle Scholar
• Bihari D, Hughes RD, Gimson AE, et al. Effects of serial resin hemoperfusion in fulminant hepatic failure. Int. J. Art if Organs 1983; 6: 299–302.
   PubMed Web of Science ®Google Scholar
• Nagaki M, Hughes RD, Lau JY, Williams R. Removal of endotoxin and cytokines by adsorbents and the effect of plasma protein binding. Int. J. Artif. Organs 1991; 14: 43–50.
   PubMed Web of Science ®Google Scholar
• Nagaki M, Hughes RD, Keane HM, Lau JY, Williams R. In vitro plasma perfusion through adsorbents and plasma ultrafiltration to remove endotoxin and cytokines. Circ. Shock 1992; 38: 182–188.
   Google Scholar
• Ash SR, Blake DE, Can DJ, Harker KD. Push-pull sorbent based pheresis for treatment of acute hepatic failure: the BioLogic-detoxifier/plasma filter System. ASAIO. J. 1998; 44: 129–139.
   PubMed Web of Science ®Google Scholar
• Ash SR, Can DJ, Blake DE, Rainier JB, Demetriou AA, Rozga J. Effect of sorbent-based dialytic therapy with the BioLogic-DT on an experimental model of hepatic failure. ASAIO. J. 1993; 39: M675–80.
   PubMedGoogle Scholar
• Ash SR, Blake DE, Carr DJ, Carter C, Howard T, Makowka L. Clinical effects of a sorbent suspension dialysis system in treatment of hepatic coma (the BioLogic-DT). Int. J. Artif. Organs 1992; 15: 151–161.
   PubMed Web of Science ®Google Scholar
• Ash SR, Blake DE, Carr DJ, Carter C, Howard T, Makowka L. Neurologic improvement of patients with hepatic failure and coma during sorbent suspension dialysis. ASAIO. Trans. 1991; 37: M332–4.
   PubMedGoogle Scholar
• Hughes RD, Pucknell A, Routley D, Langley PG, Wendon JA, Williams R. Evaluation of the BioLogic-DT sorbent-suspension dialyser in patients with fulminant hepatic failure. Int. J. Artif. Organs 1994; 17: 657–662.
   PubMed Web of Science ®Google Scholar
• Lepore MJ, Stutman U, Bonanno CA, Conklin EF, Robilotti JG, Jr., McKenna PJ. Plasmapheresis with plasma exchange in hepatic coma. II. Fulminant viral hepatitis as a systemic disease. Arch. Intern. Med. 1972; 129: 900–907.
   Google Scholar
• Buckner CD, Clift RA, Volwiler W, et al. Plasma exchange in patients with fulminant hepatic failure. Arch. Intern. Med. 1973; 132: 487–492.
   PubMed Web of Science ®Google Scholar
• Kondrup J, Almdal T, Vilstrup H, Tygstrup N. High volume plasma exchange in fulminant hepatic failure. Int. J. Artif. Organs 1992; 15: 669–676.
   PubMed Web of Science ®Google Scholar
• Larsen FS, Hansen BA, Jorgensen LG, Secher NH, Kirkegaard P, Tygstrup N. High-volume plasmapheresis and acute liver transplantation in fulminant hepatic failure. Transplant. Proc. 1994; 26: 1788–1788.
   PubMed Web of Science ®Google Scholar
• Larsen FS, Hansen BA, Ejlersen E, et al. Cerebral blood flow, oxygen metabolism and transcranial Doppler sonography during high-volume plasmapheresis in fulminant hepatic failure. Fur. J. Gastroenterol. Hepatol. 1996; 8: 261–265.
   Web of Science ®Google Scholar
• Hon i M, Austen WG, McDermott WV, Jr. Role of hepatic arterial blood flow and hepatic nerves on renal circulation and function. II. Chronic studies in the dog. Ann. Surg. 1965; 162: 949–958.
   Google Scholar
• Hon i M, Neto AC, Austen WG, McDermott WV, Jr. Isolated in vivo hepatorenal perfusion in the dog. Circulatory and functional response of the kidney to hepatic anoxia. J. Surg. Res. 1967; 7: 413–417.
   Google Scholar
• Eiseman B, Liem DS, Raffucci F. Heterologous liver perfusion in treatment of hepatic failure. Ann. Surg. 1965; 162: 329–345.
   Google Scholar
• Abouna GM. Improved technique of exchange transfusion for hepatic coma. Surg. Gynecol. Obstet. 1972; 134: 658–662.
   PubMedGoogle Scholar
• Abouna GM. Extracorporeal liver perfusion for hepatic coma. Lancet 1971; 1: 1185–1185.
   PubMed Web of Science ®Google Scholar
• Lie TS, Dengler HJ, Gutgemann A, et al. [Extracorporeal perfusion with baboon liver in the treatment of hepatic coma (author's transl)]. Dtsch. Med. Wochenschr. 1977; 102: 1506–1511.
   PubMed Web of Science ®Google Scholar
• Lie TS, Gutgemann A, Siedeck M, et al. [Treatment of hepatic coma using extracorporeal perfusion with baboon and human liver as well as with activated charcoal]. Langenbecks. Arch. Chir. 1976; Suppl: 99–103.
   Google Scholar
• Lie TS, Ronschke A, Ukigusa M, Rommelsheim K [Indication for the treatment of hepatic failure with baboon liver perfusion]. MMW. Munch. Med. Wochenschr. 1983; 125: 223–226.
   PubMedGoogle Scholar
• Fox IJ, Langnas AN, Fristoe LW, et al. Successful application of extracorporeal liver perfusion: a technology whose time has come. Am. J. Gastroenterol. 1993; 88: 1876–1881.
   PubMed Web of Science ®Google Scholar
• Byrne GW, McCurry KR, Martin MJ, McClellan SM, Platt JL, Logan JS. Transgenic pigs expressing human CD59 and decay-accelerating factor produce an intrinsic barrier to complement-mediated damage. Transplantation 1997; 63: 149–155.
   PubMed Web of Science ®Google Scholar
• Pascher A, Poehlein C, Storck M, et al. Immunopathological observations after xenogeneic liver perfusions using donor pigs transgenic for human decay- accelerating factor. Transplantation 1997; 64: 384–391.
   PubMed Web of Science ®Google Scholar
• Pascher A, Stangl M, Hammer C. Impact of immunoad-sorption on complement activation, immunopathology, and hepatic perfusion during xenogeneic pig liver perfusion. Transplantation 1998; 65: 737–740.
   Google Scholar
• Yun S, Gustafsson K, Fabre JW. Suppression of human anti-porcine T-cell immune responses by major histo-compatibility complex class II transactivator constructs lacking the amino terminal domain. Transplantation 1998; 66: 103–111.
   Google Scholar
• Hammer C, Linke R, Wagner F, Diefenbeck M. Organs from animals for man. Int. Arch. Allergy Immun. 1998; 116: 5–21.
   PubMed Web of Science ®Google Scholar
• Osanai M, Ogawa K, Lee GH. Phenobarbital causes apoptosis in conditionally immortalized mouse hepatocytes depending on deregulated c-myc expression: characterization of an unexpected effect. Cancer Res. 1997; 57: 2896–2903.
   Google Scholar
• Elcin YM, Dixit V. Gitnick G. Hepatocyte attachment on biodegradable modified chitosan membranes: In vitro evaluation for the development of liver organoids. Artificial Organs 1998; 22: 837–846.
   Google Scholar
• Lora JM, Rowader KE, Soares L, Giancotti F, Zaret KS. alpha(3)beta(1)-integrin as a critical mediator of the hepatic differentiation response to the extracellular matrix. Hepatology 1998; 28: 1095–1104.
   Google Scholar
• Selden C, Roberts E, Stamp G, et al. Comparison of three solid phase supports for promoting three-dimensional growth and function of human liver cell lines. Artificial Organs 1998; 22: 308–319.
   PubMed Web of Science ®Google Scholar
• Sussman NL, Chong MG, Koussayer T, et al. Reversal of fulminant hepatic failure using an extracorporeal liver assist device. Hepatology 1992; 16: 60–65.
   PubMed Web of Science ®Google Scholar
• Rozga J, Williams F, Ro MS, et al. Development of a bioartificial liver: properties and function of a hollow-fiber module inoculated with liver cells. Hepatology 1993; 17: 258–265.
   PubMed Web of Science ®Google Scholar
• Rozga J, Holzman MD, Ro MS, et al. Development of a hybrid bioartificial liver. Ann. Surg. 1993; 217: 502–509.
   PubMed Web of Science ®Google Scholar
• Kelly JH, Koussayer T, He D, Chong MG, Sussman NL. Assessment of an extracorporeal assist device in anhepatic dogs. Artificial Organs 1992; 16: 418–422.
   Google Scholar
• Wood RP, Katz SM, Ozaki CF, et al. Extracorporeal liver assist device (ELAD): a preliminary report. Transplant. Proc. 1993; 25: 53–54.
   PubMed Web of Science ®Google Scholar
• Sussman NL, Gislason GT, Conlin CA, Kelly JR. The Hepatix extracorporeal liver assist device: initial clinical experience. Artif. Organs 1994; 18: 390–396.
   PubMed Web of Science ®Google Scholar
• Kelly JH, Sussman NL. The hepatix extracorporeal liver assist device in the treatment of fulminant hepatic failure. ASAIO. J. 1994; 40: 83–85.
   PubMedGoogle Scholar
• Ellis AJ, Hughes RD, Wendon JA, et al. Pilot-controlled trial of the extracorporeal liver assist device in acute liver failure. Hepatology 1996; 24: 1446–1451.
   PubMed Web of Science ®Google Scholar
• Neuzil DF, Rozga J, Moscioni AD, et al. Use of a novel bioartificial liver in a patient with acute liver insufficiency. Surgery 1993; 113: 340–343.
   PubMed Web of Science ®Google Scholar
• Demetriou AA, Rozga J, Podesta L, et al. Early clinical experience with a hybrid bioartificial liver. Scand. J. Gastroenterol. Suppl. 1995; 208: 111–117.
   PubMedGoogle Scholar
• Chen SC, Hewitt WR, Watanabe FD, et al. Clinical experience with a porcine hepatocyte-based liver support system. Int. J. Artif. Organs 1996; 664–669.
   PubMed Web of Science ®Google Scholar
• Watanabe FD, Mullon CJ, Hewitt WR, et al. Clinical experience with a bioartificial liver in the treatment of severe liver failure. A phase I clinical trial. Ann. Surg. 1997; 484–491.
   Google Scholar
• Rozga J, Podesta L, Lepage E, et al. A bioartificial liver to treat severe acute liver failure. Ann. Surg. 1994; 219: 538–544.
   PubMed Web of Science ®Google Scholar
• Naik S, Trenkler D, Santangini H, Pan J, Jauregui HO. Isolation and culture of porcine hepatocytes for artificial liver support. Cell Transplant 1996; 5: 107–115.
   Google Scholar
• Jauregui HO, Gann KL. Mammalian hepatocytes as a foundation for treatment in human liver failure. J. Cell Biochem. 1991; 45: 359–365.
   PubMed Web of Science ®Google Scholar
• Keen JH, Jakoby WB. Glutathione transferases. Catalysis of nucleophilic reactions of glutathione. J. Biol. Chem. 1978; 253: 5654–5657.
   Google Scholar
• Kurose I, Wolf R, Grisham MB, AW TY, Specian RD, Granger DN. Microvascular responses to inhibition of nitric oxide production. Role of active oxidants. Circ. Res. 1995; 76: 30–39.
   Google Scholar
• Mimic Oka J, Simic T. Time course of renal glutathione levels in experimental Fanconi syndrome: an enzyme-based approach. Ren. Fail. 1997; 19: 373–381.
   PubMed Web of Science ®Google Scholar
• Sutherland DE, Numata M, Matas AJ, Simmons RL, Najarian JS. Hepatocellular transplantation in acute liver failure. Surgery 1977; 82: 124–132.
   Google Scholar
• Sommer BG, Sutherland DE, Matas AJ, Simmons RL, Najarian JS. Hepatocellular transplantation for treatment of D-galactosamine-induced acute liver failure in rats. Transplant. Proc. 1979; 11: 578–584.
   Google Scholar
• Sun AM, Cai Z, Shi Z, Ma F, O'Shea GM. Microencapsulated hepatocytes: an in vitro and in vivo study. Biomater. Artif. Cells Artif. Organs 1987; 15: 483–496.
   PubMed Web of Science ®Google Scholar
• Habibullah CM, Syed IFI, Qamar A, Taher-Uz Z. Human fetal hepatocyte transplantation in patients with fulminant hepatic failure. Transplantation 1994; 58: 951–952.
   Google Scholar
• Soriana HE, Wood RP, Kang DC, Ferry GD. Hepatocellular Transplantation (HCT) In Children With Fulminant Liver Failure (ELF). Hepatology 1997; 26: 239A–239A.
   Google Scholar
• Bilk BM, Guenette D, Ostrowska A, Durham J. Percutaneous Hepatocyte transplantation (PHT) In Liver Failure. Hepatology 1997; 26: 252A–252A.
   Google Scholar
• Strom SC, Fisher RA, Thompson MT, et al. Hepatocyte transplantation as a bridge to orthotopic liver transplantation in terminal liver failure. Transplantation 1997; 63: 559–569.
   PubMed Web of Science ®Google Scholar
• Bernal W, Donaldson P, Underhill J, Wendon J, Williams R. Tumor necrosis factor genomic polymorphism and outcome of acetaminophen (paracetamol)-induced acute liver failure. J. Hepatol. 1998; 29: 53–59.
   Google Scholar
• Keynes WM. Haemodialysis in the treatment of liver failure. Lancet 1968; 2: 1236–1238.
   PubMed Web of Science ®Google Scholar